Scholarly Index

Joaquim Bellmunt

Dana-Farber Cancer Institute; 62,619 total citations; 936 total publications; best world rank #5

Dana-Farber Cancer Institute

62,619Total citations

936Total publications

104H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Medical and Health Sciences	2021-2025	831	US 293	99.81
Surgery	Lifetime	85	US 47	99.93
Pulmonary and Respiratory Medicine	Lifetime	188	US 99	99.76
Oncology	Lifetime	543	US 300	98.99
Cancer Research	Lifetime	471	US 245	97.06
Urology	Lifetime	678	US 293	84.43
Surgery	2021-2025	34	US 14	99.79
Oncology	2021-2025	326	US 135	96.78
Pulmonary and Respiratory Medicine	2021-2025	737	US 268	90.70
Bladder and Urothelial Cancer Treatments	Lifetime	7	US 6	99.89
Urinary and Genital Oncology Studies	Lifetime	5	US 4	99.90
Ferroptosis and cancer prognosis	Lifetime	19	US 9	99.54
Multiple and Secondary Primary Cancers	Lifetime	13	US 4	99.74
Renal cell carcinoma treatment	Lifetime	29	US 22	99.76
Cancer Immunotherapy and Biomarkers	Lifetime	63	US 38	99.81
Renal and related cancers	Lifetime	84	US 58	99.38
Cancer Genomics and Diagnostics	Lifetime	193	US 122	99.58
Prostate Cancer Treatment and Research	Lifetime	232	US 135	99.24
Cancer, Lipids, and Metabolism	Lifetime	283	US 153	98.83
Urological Disorders and Treatments	Lifetime	377	US 222	98.37
Epigenetics and DNA Methylation	Lifetime	808	US 423	98.17
Esophageal Cancer Research and Treatment	Lifetime	305	US 121	98.27
Prostate Cancer Diagnosis and Treatment	Lifetime	768	US 371	97.74
Fibroblast Growth Factor Research	Lifetime	518	US 220	93.77
Economic and Financial Impacts of Cancer	Lifetime	683	US 433	93.61
Infectious Disease Case Reports and Treatments	Lifetime	137	US 76	89.08
Bladder and Urothelial Cancer Treatments	2021-2025	14	US 8	99.69
Urinary and Genital Oncology Studies	2021-2025	14	US 7	99.61
Multiple and Secondary Primary Cancers	2021-2025	12	US 7	98.00
Cancer Immunotherapy and Biomarkers	2021-2025	183	US 72	99.30
Renal cell carcinoma treatment	2021-2025	180	US 71	97.00
Esophageal Cancer Research and Treatment	2021-2025	179	US 30	96.12
Urological Disorders and Treatments	2021-2025	563	US 161	88.12
Fibroblast Growth Factor Research	2021-2025	299	US 96	76.02
Infectious Disease Case Reports and Treatments	2021-2025	216	US 62	39.55